Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1997-01-28
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544325, A61K 31505, C07D23948
Patent
active
055978282
ABSTRACT:
A class of substituted phenylpyrimidine compounds are disclosed which are potent inhibitors of the excitatory amino acid, glutamate. Such compounds are useful in the treatment or prevention of a range of CNS disorders including cerebral ischaemic damage and epilepsy.
REFERENCES:
patent: 2576939 (1951-12-01), Hitchings
patent: 2594309 (1952-04-01), Hitchings
patent: 2602794 (1952-07-01), Hitchings
patent: 2624731 (1953-01-01), Hitchings et al.
patent: 2688019 (1954-08-01), Hitchings et al.
patent: 3940393 (1976-02-01), Greenspan et al.
patent: 3956327 (1976-05-01), Cresswell
patent: 3980781 (1976-09-01), Snell et al.
patent: 4005204 (1977-01-01), Stickney et al.
patent: 4006235 (1977-02-01), Stickney et al.
patent: 4024145 (1977-05-01), Kompis
patent: 4725600 (1988-02-01), Takaya et al.
patent: 4789743 (1988-12-01), Becker
patent: 5136080 (1992-08-01), Miller et al.
Falco et al Brit J. Pharmacol 1951 6, 185.2:4-Diaminopyrimidines--A new series of Antimalarials.
Russell et al JACS 8/51, pp. 3763-3770 "2,4-Diaminopyrimidines as Antimalarials".
Lux vol. IV No. 9 1954 pp. 971-977 Antibiotics and Chemotherapy "The Chemotherapy of Eimeria tenella".
Budesinskey--Ceskoslov, farm, 15 (1966) pp. 433-437 "5-arylpyrimidiny.III."*).
Roth et al J. Org. Chem No. 4 1969 pp. 821-836 "The Protonation of 2,4-Diaminopyrimidines . . . ".
Cody et al J. Med. Chem. 1982, 25, 427-430 "Molecular Structures of 2,4-Diaminopyrimidine Antifolates . . . ".
McCullough et al Biochemical Pharmacology, vol. 20 pp. 561-574 1971 "Dihydrofolate Reductase from Mouse . . . ".
Cohn Patents and Designs Ordinance Israel "New 2:4-diamino-5-phenyl-6-alkyl pyrimidine . . . " pp. 1-4.
Biziere, et al., "Chemical Abstracts", vol. 105, 1986, Col. 105:973;19h.
Cody, et al., Structural Analysis of Lipophilic Antifolates: Electronic Structure, Conformation and Enzyme Binding.
Cody, et al., Structure-Activity Relationships Among 5-Substituted Lipophilic Diaminopyrimidine Antieoplastic Antifolates.
Ioan Motoc, Match on the Minimal Steric Difference Method.
Russell et al., J. A. C. S., vol. 73, pp. 3763-3770 (1951).
Falco et al., British J. of Pharmacology, vol. 6, pp. 185-200 (1951).
Hyde Richard M.
Leach Michael J.
Miller Alistair A.
Nobbs Malcolm S.
Dentz Bernard
Glaxo Wellcome Inc.
LandOfFree
Certain 2,4-diamino-5-(2,3-dihalophenyl)-6-substituted pyrimidin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain 2,4-diamino-5-(2,3-dihalophenyl)-6-substituted pyrimidin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain 2,4-diamino-5-(2,3-dihalophenyl)-6-substituted pyrimidin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-941685